Related Experiment Video

Updated: Mar 31, 2026

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.9K

Looking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium Survival

Seahyoung Lee1, Eunhyun Choi1, Min-Ji Cha1

  • 1Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung-si, Gangwon-do 210-701, Republic of Korea ; Catholic Kwandong University International St. Mary's Hospital, Incheon Metropolitan City 404-834, Republic of Korea.

Mediators of Inflammation
|October 23, 2015
PubMed

Insights

MicroRNAs (miRNAs) regulate pyroptosis, a distinct cell death pathway. This review explores miRNAs

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Pyroptosis is a pro-inflammatory regulated cell death mechanism.
  • Distinct from apoptosis and necrosis, pyroptosis involves unique cellular events.
  • Emerging evidence implicates microRNAs (miRNAs) in pyroptosis regulation.

Purpose of the Study:

  • To provide an updated review on the role of miRNAs in pyroptosis.
  • To highlight the connection between miRNAs, pyroptosis, and cardiovascular diseases (CVDs).
  • To suggest future research directions for therapeutic targeting of miRNAs in CVDs.

Main Methods:

  • Literature review of existing studies on miRNAs and pyroptosis.
  • Analysis of current data linking miRNA-mediated pyroptosis to CVDs.
  • Identification of research gaps and future therapeutic strategies.

Main Results:

  • Limited empirical data currently exists on miRNA-dependent pyroptosis.
  • miRNAs are increasingly recognized as key regulators of pyroptosis.
  • miRNAs represent potential therapeutic targets for managing myocardial cell death in CVDs.

Conclusions:

  • miRNAs play a significant role in the intricate regulation of pyroptosis.
  • Further investigation is needed to elucidate the specific mechanisms.
  • Targeting miRNAs offers a promising therapeutic avenue for cardiovascular diseases.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K